Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes | Zendy

Jingya Wang | Zendy; Jennifer Cooper | Zendy; Krishna Gokhale | Zendy; Dionisio Acosta | Zendy; Samir Dhalla | Zendy; Nathan Byne | Zendy; Joht Singh Chandan | Zendy; Astha Anand | Zendy; Kelvin Okoth | Zendy; Anuradhaa Subramanian | Zendy; Mansoor N. Bangash | Zendy; Thomas Jackson | Zendy; Dawit Zemedikun | Zendy; Tom Taverner | Zendy; Wasim Hanif | Zendy; Sandip Ghosh | Zendy; Parth Narendran | Zendy; Konstantinos A. Toulis | Zendy; Abd A. Tahrani | Zendy; Rajendra Surenthirakumaran | Zendy; Nicola J. Adderley | Zendy; Shamil Haroon | Zendy; Kamlesh Khunti | Zendy; Christopher Sainsbury | Zendy; G. Neil Thomas | Zendy; Krishnarajah Nirantharakumar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes

Author(s) -

Jingya Wang,

Jennifer Cooper,

Krishna Gokhale,

Dionisio Acosta,

Samir Dhalla,

Nathan Byne,

Joht Singh Chandan,

Astha Anand,

Kelvin Okoth,

Anuradhaa Subramanian,

Mansoor N. Bangash,

Thomas Jackson,

Dawit Zemedikun,

Tom Taverner,

Wasim Hanif,

Sandip Ghosh,

Parth Narendran,

Konstantinos A. Toulis,

Abd A. Tahrani,

Rajendra Surenthirakumaran,

Nicola J. Adderley,

Shamil Haroon,

Kamlesh Khunti,

Christopher Sainsbury,

G. Neil Thomas,

Krishnarajah Nirantharakumar

Publication year - 2021

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/clinem/dgab067

Subject(s) - metformin , medicine , propensity score matching , confounding , type 2 diabetes , diabetes mellitus , glycemic , hazard ratio , medical prescription , proportional hazards model , risk factor , pharmacology , insulin , endocrinology , confidence interval

Diabetes has emerged as an important risk factor for mortality from COVID-19. Metformin, the most commonly prescribed glucose-lowering agent, has been proposed to influence susceptibility to and outcomes of COVID-19 via multiple mechanisms. We investigated whether, in patients with diabetes, metformin is associated with susceptibility to COVID-19 and its outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research